SCHEDULE: Conestoga Capital Advisors Discloses 6.73% Stake in Lemaitre Vascular

Conestoga Capital Advisors has reported a beneficial ownership of 6.73% in Lemaitre Vascular Inc., holding over 1.5 million shares as of December 31, 2025.

Summary

• Conestoga Capital Advisors, a Delaware-based investment adviser, has filed a Schedule 13G indicating beneficial ownership in Lemaitre Vascular Inc.
• The firm beneficially owns 1,527,429 shares of Lemaitre Vascular Inc.'s Common Stock.
• This ownership represents 6.73% of the class of securities.
• Conestoga Capital Advisors holds sole voting power over 1,424,988 shares and sole dispositive power over 1,527,429 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates a significant institutional investment, which is generally viewed as a positive signal of confidence in the company, though it does not provide operational or financial performance details.

Positives

• Increased institutional ownership by Conestoga Capital Advisors signals confidence in Lemaitre Vascular Inc.'s long-term prospects.
• The investment is stated to be for ordinary course of business, indicating a passive, long-term investment strategy rather than an activist one.

Future Outlook

This filing does not contain forward-looking statements or guidance from Lemaitre Vascular Inc. or Conestoga Capital Advisors regarding future performance or strategy.

Industry Context

The disclosure of a significant stake by an investment adviser like Conestoga Capital Advisors in a medical device company such as Lemaitre Vascular Inc. reflects ongoing institutional interest in the healthcare sector, particularly in specialized areas like vascular products. Such investments often indicate a belief in the company's market position, innovation, and growth potential within its niche.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may instill greater confidence among existing and potential shareholders, potentially influencing stock valuation positively.
• Company Management: Awareness of a substantial institutional holder may influence management's strategic decisions, though the filing states the investment is passive.

Key Dates

Keywords

Lemaitre Vascular Inc, Conestoga Capital Advisors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, Medical Devices, Vascular, SEC Filing